Home > Insider Trading > Filing (0000914190-21-000306)

Filing Details

Accession Number:: 0000914190-21-000306
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-08-25 16:42:02
Reporting Period:: 2021-08-23

Accepted Time:: 2021-08-25 16:42:02
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
842023	Bio-Techne Corp	TECH	Biological Products, (No Disgnostic Substances) (2836)	411427402

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1258704	V Robert Baumgartner	5775 Wayzata Boulevard, Suite 400 Minneapolis MN 55416		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-08-23	4,000	$87.39	13,612	No	4	M	Direct
Common Stock	Disposition	2021-08-23	299	$481.77	13,313	No	4	S	Direct
Common Stock	Disposition	2021-08-23	601	$483.60	12,712	No	4	S	Direct
Common Stock	Disposition	2021-08-23	600	$485.03	12,112	No	4	S	Direct
Common Stock	Disposition	2021-08-23	1,600	$486.25	10,512	No	4	S	Direct
Common Stock	Disposition	2021-08-23	800	$487.10	9,712	No	4	S	Direct
Common Stock	Disposition	2021-08-23	100	$487.88	9,612	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (right to buy)	Disposition	2021-08-23	4,000	$0.00	4,000	$87.39

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2013-10-31	2023-10-30	No	4	M	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Options (right to buy)	$91.78	2014-10-30	2024-10-30	4,000	4,000	Direct
Common Stock	Stock Options (right to buy)	$87.34	2016-10-29	2025-10-28	4,260	4,260	Direct
Common Stock	Stock Options (right to buy)	$101.19	2017-10-26	2026-10-26	3,985	3,985	Direct
Common Stock	Stock Options (right to buy)	$125.05	2018-10-25	2027-10-26	3,125	3,125	Direct
Common Stock	Stock Options (right to buy)	$179.84	2019-10-24	2028-10-25	1,898	1,898	Direct
Common Stock	Stock Options (right to buy)	$201.64	2020-10-24	2029-10-24	2,011	2,011	Direct
Common Stock	Stock Options (right to buy)	$255.69		2030-10-29	1,507	1,507	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2024-10-30	4,000	4,000	Direct
2025-10-28	4,260	4,260	Direct
2026-10-26	3,985	3,985	Direct
2027-10-26	3,125	3,125	Direct
2028-10-25	1,898	1,898	Direct
2029-10-24	2,011	2,011	Direct
2030-10-29	1,507	1,507	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $481.41 to $482.40, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $483.01 to $483.86, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $484.52 to $485.51, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $485.59 to $486.51, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $486.84 to $487.52, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $487.87 to $487.89, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option vests on the earlier of the one year anniversary of the grant date (10/29/20) or the date of Bio-Techne's 2021 annual meeting of shareholders.